As FOXG1 is also observed to be dysregulated in various types of cancer including hepatoblastoma, medulloblastoma, breast cancer, and ovarian cancer (Adesina et al., 2007; Chan et al., 2009; Li et al., 2013), it is plausible that aberrant regulation of FOXG1 expression outside of the nervous system also triggers dysregulated cell cycle and tumorigenesis in pathological conditions. This evidence concerns the gene FOXG1 and ovarian carcinoma.